Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B

Authors: Papadopoulos, Vasileios1; Protopapas, Andreas2; Tsianos, Epameinondas3; Mimidis, Konstantinos1

Source: Scandinavian Journal of Gastroenterology, Volume 44, Number 8, August 2009 , pp. 1021-1022(2)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $34.29 plus tax (Refund Policy)

Document Type: Research article

DOI: http://dx.doi.org/10.1080/00365520902937370

Affiliations: 1: First Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece 2: Department of Gastroenterology, Giannitsa General Hospital, Giannitsa, Greece 3: First Department of Internal Medicine and Hepato-Gastroenterology Unit, Medical School, University of Ioannina, Ioannina, Greece

Publication date: 2009-08-01

More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page